Pharmacokinetic-pharmacodynamic modeling of the anticancer effect of erlotinib in a human non-small cell lung cancer xenograft mouse model

AIM: Erlotinib is used to treat non-small-cell lung cancer (NSCLC), which targets epidermal growth factor receptor (EGFR) tyrosine kinase. The aim of this study was to investigate the relationship between erlotinib plasma concentrations and phosphorylated EGFR (pEGFR) levels, as well as the relation...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Wu, Qiong, Li, Meng-yao, Li, Han-qing, Deng, Chen-hui, Li, Liang, Zhou, Tian-yan, Lu, Wei
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2013
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4006468/
https://ncbi.nlm.nih.gov/pubmed/24096601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2013.101
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky